Table 1.
Characteristic of the studied brain tumor patients.
| Characteristics | Cohort (n = 29) | |
|---|---|---|
| Gender | Male | 16 (55.3%) |
| Female | 13 (44.8%) | |
| Age (year) (median; minimum-maximum) | 42 (26–79) | |
| Survival status | Alive | 17 (58.6%) |
| Dead | 10 (34.5%) | |
| NA | 2 (6.9%) | |
| Survival (month) (median; minimum-maximum) | 17 (2–108) | |
| Laterality | Left | 12 (41.4%) |
| Right | 17 (58.6%) | |
| Localization | Frontal | 18 (62.1%) |
| Temporal | 1 (3.4%) | |
| Occipital | 1 (3.4%) | |
| Parietal | 5 (17.2%) | |
| Insular | 4 (13.8%) | |
| Post 18F-FET histology | A2 | 2 (6.9%) |
| A3 | 2 (6.9%) | |
| A4 | 7 (24.1%) | |
| GBM | 6 (20.7%) | |
| E3 | 1 (3.3%) | |
| O2 | 3 (10.3%) | |
| O3 | 7 (24.1%) | |
| ETMR | 1 (3.4%) | |
| TBRmax (median; minimum-maximum) | 2.66 (0.81–5.3) | |
| TBRmax | <1.6 | 3 (10.3%) |
| ≥1.6 | 26 (89.7%) | |
| Ki67 (%) (median; minimum-maximum) | 10 (3–80) | |
| Grade | 2 | 5 (17.2%) |
| 3–4 | 24 (82.8%) | |
| IDH-status | wild-type | 10 (34.5%) |
| mutant | 18 (62.1%) | |
| NA | 1 (3.4%) | |
| MRI contrast enhancement | no | 15 (51.7%) |
| yes | 14 (48.3%) | |
| elevated MRI perfusion | no | 17 (58.6%) |
| yes | 6 (20.7%) | |
| NA | 6 (20.7%) |